Emily Brown

2.6k total citations · 1 hit paper
44 papers, 1.3k citations indexed

About

Emily Brown is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Emily Brown has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Emily Brown's work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes Treatment and Management (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Emily Brown is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diabetes Treatment and Management (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Emily Brown collaborates with scholars based in United Kingdom, United States and Canada. Emily Brown's co-authors include Daniel J. Cuthbertson, John Wilding, Hiddo J.L. Heerspink, Uazman Alam, Thomas M. Barber, Surya Panicker Rajeev, Amy C. Sturm, Robert A. Hegele, Marina Cuchel and Lynne T. Braun and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Emily Brown

41 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications

2021 355 citations Emily Brown, Daniel J. Cuthbertson et al. profile →

Peers

Emily Brown

EDM

SURGE

CCM

EPIDE

Dimitrios Patoulias Greece

Hajime Izumiyama Japan

Naila Goldenberg United States

Yoshihito Atsumi Japan

Marja Pyörälä Finland

Andromachi Vryonidou Greece

Qiuhe Ji China

Florian M.M. Baeres Denmark

Søren Tang Knudsen Denmark

MaryAnn Banerji United States

Dimitrios Patoulias Greece

Emily Brown

674 ×1.0

EDM

393 ×1.1

SURGE

547 ×1.5

CCM

283 ×1.1

176 ×0.8

EPIDE

Citations per year, relative to Emily Brown Emily Brown (= 1×) peers Dimitrios Patoulias

Countries citing papers authored by Emily Brown

Since Specialization

Citations

This map shows the geographic impact of Emily Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Brown more than expected).

Fields of papers citing papers by Emily Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Brown. The network helps show where Emily Brown may publish in the future.

Co-authorship network of co-authors of Emily Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Brown. A scholar is included among the top collaborators of Emily Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Brown. Emily Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rajeev, Surya Panicker, Carl Roberts, Emily Brown, et al.. (2023). No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled, cross‐over trial (ENERGIZE). Diabetes Obesity and Metabolism. 25(12). 3621–3631. 4 indexed citations

Brown, Emily & Brittney Murray. (2023). A Practical Guide to Genetic Testing in Inherited Heart Disease. Cardiac Electrophysiology Clinics. 15(3). 241–247.

Thomaides‐Brears, Helena, Rajarshi Banerjee, Daniel J. Cuthbertson, et al.. (2022). Greater ectopic fat deposition and liver fibroinflammation and lower skeletal muscle mass in people with type 2 diabetes. Obesity. 30(6). 1231–1238. 21 indexed citations

Young, Lisa R., Emily Brown, & Seth S. Martin. (2022). Homozygous Familial Hypercholesterolemia. JACC Case Reports. 4(23). 101666–101666. 1 indexed citations

Williams, S., Muhammad Ilyas Khan, Prathap Kanagala, et al.. (2022). Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management. Clinical Therapeutics. 44(10). 1394–1416. 39 indexed citations

James, Cynthia A., Jan D.H. Jongbloed, Ray E. Hershberger, et al.. (2021). International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework. Circulation Genomic and Precision Medicine. 14(3). e003273–e003273. 110 indexed citations

Brown, Emily, Victoria S. Sprung, Joanne A. Harrold, et al.. (2021). A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol. BMJ Open. 11(7). e045663–e045663. 9 indexed citations

Hydes, Theresa, Emily Brown, Adila A. Hamid, Adrian C Bateman, & Daniel J. Cuthbertson. (2021). Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications. Clinical Therapeutics. 43(9). 1505–1522. 13 indexed citations

Brown, Emily, Theresa Hydes, Adila A. Hamid, & Daniel J. Cuthbertson. (2021). Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. Clinical Therapeutics. 43(9). 1476–1504. 18 indexed citations

10.

Eleftheriadou, Aikaterini, S. Williams, Sarah J Nevitt, et al.. (2020). The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review. Diabetologia. 64(2). 288–303. 39 indexed citations

11.

Brown, Emily, Amy C. Sturm, Marina Cuchel, et al.. (2020). Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association. Journal of clinical lipidology. 14(4). 398–413. 76 indexed citations

12.

Binder, Michael, Emily Brown, Thomas Aversano, et al.. (2020). Novel FHL1 Mutation Associated With Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and Myopathy. SHILAP Revista de lepidopterología. 2(3). 372–377. 3 indexed citations

13.

Brown, Emily, Kathleen Byrne, Dorothy M. Davis, et al.. (2020). Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia. Journal of clinical lipidology. 14(3). 331–338. 4 indexed citations

14.

Brown, Emily, Marc K. Halushka, William Ravekes, et al.. (2019). Genetic aetiologies should be considered in paediatric cases of acute heart failure presumed to be myocarditis. Cardiology in the Young. 29(7). 917–921. 17 indexed citations

15.

Quispe, Renato, Seth S. Martin, Emily Brown, et al.. (2019). Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7. Archives of Medical Science. 15(5). 1195–1202. 16 indexed citations

16.

Pallazola, Vincent A., Vasanth Sathiyakumar, Jihwan Park, et al.. (2019). Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia). Archives of Medical Science. 16(5). 993–1003. 23 indexed citations

17.

Kapoor, Karan, Emily Brown, Thorsten M. Leucker, et al.. (2019). Novel Presentation of Homozygous Familial Hypercholesterolemia With Homozygous Variants in Both LDLR and APOB Genes. SHILAP Revista de lepidopterología. 1(3). 346–349. 1 indexed citations

18.

Brown, Emily, Daniel J. Cuthbertson, & John Wilding. (2018). Newer GLP-1 receptor agonists and obesity-diabetes. Peptides. 100. 61–67. 65 indexed citations

19.

Shackcloth, Daniela, et al.. (2012). PMO-242 The IBD-control questionnaire: development and psychometric validation of a tool for capturing disease control from the patient perspective for use in routine care. Gut. 61(Suppl 2). A173.1–A173. 1 indexed citations

20.

Brown, Emily. (1985). The Comprehensive Divorce Treatment Center: The Divorce and Marital Stress Clinic Model. 1(3). 159–169. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact